Randy Milby

President at

Hillstream Pharma, Inc.

72 year

46 connections

Health Technology

Process Industries

Consumer Services

Profile

Randy D.
Milby was the founder of Canton Strategic Holdings, Inc., founded in 2017, where the title held was Chief Executive Officer & Director in 2025.
Mr. Milby was the founder of WaterStone Bridge LLC, founded in 2010, holding the title of Managing Director.
Current jobs include President, Secretary & Director at Hillstream Pharma, Inc. since 2012, with employment starting in 2006, and Managing Partner at MW Bridges LLC.
Former jobs include CEO, Director & Head-Investor Relations at CorMedix, Inc. from 2015 to 2016; Director-Global Marketing at EIDP, Inc. from 1999 to 2004; Director-Global Marketing at DuPont Crop Protection Co., Inc.; Senior Director at DuPont Merck Pharmaceutical Co.; Global Business Director-Applied BioSciences at DuPont de Nemours, Inc.; and President & Secretary at Sirion Holdings, Inc. Education includes undergraduate studies at KU School of Pharmacy and an MBA from Olin Business School.

Randy Milby active positions

Companies	Position	Start
Hillstream Pharma, Inc. Hillstream Pharma, Inc. Financial ConglomeratesFinance Operates as a blank check company	President	31/01/2006
MW Bridges LLC MW Bridges LLC Miscellaneous Commercial ServicesCommercial Services MW Bridges LLC is an American company.	Corporate Officer/Principal	-

All active positions of Randy Milby

Former positions of Randy Milby

Companies	Position	End
CANTON STRATEGIC HOLDINGS, INC.	Chief Executive Officer	11/06/2025
CORMEDIX INC.	Chief Executive Officer	02/09/2016
Sirion Holdings, Inc. Sirion Holdings, Inc. BiotechnologyHealth Technology Provides pharmaceutical products and medical devices for the ophthalmic market	President	13/09/2006
E I DU PONT DE NEMOURS AND CO	Sales & Marketing	01/01/2004
DuPont Merck Pharmaceutical Co. DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs	Director/Board Member	-

See the detail of Randy Milby's experience

Training of Randy Milby

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Randy Milby's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
EIDP, Inc. EIDP, Inc. Chemicals: AgriculturalProcess Industries Manufactures and sells seed & crop protection products	Process Industries
Hillstream Pharma, Inc. Hillstream Pharma, Inc. Financial ConglomeratesFinance Operates as a blank check company	Finance
Sirion Holdings, Inc. Sirion Holdings, Inc. BiotechnologyHealth Technology Provides pharmaceutical products and medical devices for the ophthalmic market	Health Technology
CorMedix, Inc. CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases	Health Technology
DuPont Merck Pharmaceutical Co. DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs	Health Technology
DuPont Crop Protection Co., Inc. DuPont Crop Protection Co., Inc. Chemicals: AgriculturalProcess Industries Manufactures and distributes fungicides, insecticides and herbicides	Process Industries
Olin Business School Olin Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
WaterStone Bridge LLC
MW Bridges LLC MW Bridges LLC Miscellaneous Commercial ServicesCommercial Services MW Bridges LLC is an American company.	Commercial Services
KU School of Pharmacy KU School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
DuPont de Nemours, Inc. DuPont de Nemours, Inc. Chemicals: Major DiversifiedProcess Industries Operates as a holding company which develops specialty materials, chemicals, and agricultural products	Process Industries
Tharimmune, Inc. Tharimmune, Inc. BiotechnologyHealth Technology Operates as a pre-clinical biotechnology company that develops novel therapeutic candidates targeting ferroptosis	Health Technology